The Digital Health Legal Landscape
email to a friend
About
This Course
The rapid convergence of digital technologies with healthcare over the past five years (even prior to the COVID-19 pandemic) has transformed how healthcare is delivered to the masses.
The promise of digital technologies continues to transform the healthcare delivery model from a traditional model based on a “one-size-fits-all” practice of medicine that was characterized by a provider-centric approach with information silos to a new model that is focused on patient-centric treatment personalization with high data accessibility and utilization. The result is a highly personalized healthcare system that is focused on data-driven healthcare solutions and individualized delivery of therapeutics and treatments to patients using information technologies (IT) that enable seamless integration and communication between patients, providers, payors, researchers, and health information depositories. A November 2020 report by Precedence Research published on GlobeNewsWire indicates that the global digital health market is poised to grow at a compound annual growth rate (CAGR) of around 27.9% over the next seven years to reach approximately $833.44 billion by 2027.
You are encouraged to attend this cutting-edge program if you are an attorney who advises clients on intellectual property (IP) protection for digital health innovation, protecting and utilizing data assets, and healthcare data privacy considerations. Learn how to strategically build an IP portfolio around digital health innovation that can pass muster under §101, establish a framework around data sharing with an emphasis on obtaining data rights that establish a win-win for both parties involved, identify the key healthcare and life sciences privacy regulations, the changes that are coming, and conduct a privacy review (a crucial step) before any meaningful transaction.
Learning Objectives:
- Analyze how to protect intellectual property for digital health innovation
- Evaluate data rights and how to protect and utilize your data assets
- Understand healthcare data privacy considerations
About the Presenters
Roger Kuan, Esq.
Norton Rose Fulbright US LLP
Practice Area: Health Law
Roger Kuan is the US head of the digital health and precision medicine practice and counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical ...
View Details
Jason Novak, Esq.
Norton Rose Fulbright US LLP
Practice Area: Health Law
Jason Novak is a partner in Norton Rose Fulbright’s San Francisco Office and a member of the Precision Medicine and Digital Health Practice Group, where he focuses on advising entities, both large and small, on the various legal issues that can arise with emerging technologies in the healthcare and life sciences industries. Tech and Biotech are traditionally disparate technologies that, when blended together to form many of our most exciting new technologies, bring forth a combination of unique and interrelated legal issues.
View Details
Anna Rudawski, Esq.
Norton Rose Fulbright US LLP
Practice Area: Other
Anna Rudawski is a partner in Norton Rose Fulbright’s New York Office. She focuses on data protection, privacy, and cybersecurity issues with an emphasis on the US and global privacy regulation and privacy governance. She works closely with companies on complex cybersecurity attacks and data breach investigations. She also works with clients on issues related to protecting data and assessing rights to data during transactions or reorganizations.
View Details